Recalcitrant pyoderma gangrenosum treated with thalidomide

被引：44
|
作者：
Federman, GL
Federman, DG
机构：
[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
来源：
MAYO CLINIC PROCEEDINGS | 2000年 / 75卷 / 08期
关键词：
D O I：
10.4065/75.8.842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pyoderma gangrenosum is a painful, noninfectious, ulcerating skin disorder often associated with systemic disease. Thalidomide has been used to treat many inflammatory dermatologic conditions and has been reintroduced in the United States to treat immune-modulated diseases such as pyoderma gangrenosum. The patient described, a 47-year-old man, had histologically confirmed pyoderma gangrenosum that did not respond to treatment with several courses of methylprednisolone. The ulcer healed with 10 weeks of oral thalidomide administration.
引用
收藏
页码：842 / 844
页数：3
相关论文
共 50 条
  • [21] Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab
    Low, Zhi Mei
    Mar, Adrian
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (02) : 131 - 134
  • [22] Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum
    Michelucci, Alessandra
    Margiotta, Flavia Manzo
    Granieri, Giammarco
    Salvia, Giorgia
    Fidanzi, Cristian
    Bevilacqua, Matteo
    Panduri, Salvatore
    Romanelli, Marco
    Dini, Valentina
    ADVANCES IN SKIN & WOUND CARE, 2024, 37 (05) : 276 - 279
  • [23] Treatment of Thalidomide Resistant Pyoderma Gangrenosum with Etenercept
    Guedes, Rita
    Moreira, Ana
    Menezes, Nuno
    Baptista, Armando
    Varela, Paulo
    ACTA DERMATOVENEROLOGICA CROATICA, 2012, 20 (03) : 175 - 180
  • [24] Penile pyoderma gangrenosum: Successful treatment with thalidomide
    Hu, Yu-Qing
    Yao, Xu-Xin
    Zhang, Jian-Zhong
    Li, Wen-Hai
    DERMATOLOGIC THERAPY, 2019, 32 (04)
  • [25] Pathergic pyoderma gangrenosum associated with nodular prurigo in a patient with POEMS syndrome treated with thalidomide
    Desai, N.
    Berens, J.
    Mehta, A.
    Orteu, C.
    Holden, C. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 : 32 - 32
  • [26] Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum
    Hohenleutner, U
    Mohr, VD
    Michel, S
    Landthaler, M
    LANCET, 1997, 350 (9093): : 1748 - 1748
  • [27] Recalcitrant oral pyoderma gangrenosum in a child responsive to cyclosporine
    Park, HJ
    Han, BG
    Kim, YC
    Cinn, YW
    JOURNAL OF DERMATOLOGY, 2003, 30 (08): : 612 - 616
  • [28] Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
    Becker, Sarah L.
    Velasco, Rose
    Ortega-Loayza, Alex G.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2143 - 2152
  • [29] Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report
    Vallerand, Isabelle A.
    Hardin, Jori
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [30] Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum
    Shaath, Tarek S.
    Om, Amit
    Wolfe, Christopher M.
    Cohen, George F.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (03) : 307 - 310
12345